Large gap with delayed quotes
|
Official
03/10/2026
-
01:04:00
|
Bid
03/09/2026 -
20:59:59
|
Bid Volume |
Ask
03/09/2026 -
20:59:59
|
Ask Volume |
|---|---|---|---|---|
|
252.93
+0.06
(
+0.02% )
|
252.89
|
760 |
252.91
|
1,600 |
Analysis date: 06.03.2026
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 02.12.2025.
Interest
Weak
Weak
Two stars since 06.03.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 02.12.2025 at a price of 250.85.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 13.01.2026.
4wk Rel Perf
-3.91%
-3.91%
The four-week dividend-adjusted underperformance versus SP500 is 3.91%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 24.06.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.13%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 1.98%.
Mkt Cap in $bn
37.19
37.19
With a market capitalization >$8bn, RESMED is considered a large-cap stock.
G/PE Ratio
0.84
0.84
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
18.61
18.61
The estimated PE is for the year 2028.
LT Growth
14.59%
14.59%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
22
22
Over the last seven weeks, an average of 22 analysts provided earnings per share estimates.
Dividend Yield
1.02%
1.02%
The twelve month estimated dividend yield represents 19.02% of earnings forecasts.
Beta
74
74
For 1% of index variation, the stock varies on average by 0.74%.
Correlation
0.57
0.57
56.97% of stock movements are explained by index variations.
Value at Risk
17.15
17.15
The value at risk is estimated at USD 17.15. The risk is therefore 6.78%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002